Association of TNF-α -308G/A, SP-B 1580 C/T, IL-13-1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population

Archives of Medical Science

Volumn 8, Issue 2, 2012, Pages 286-295

  Ezzeldin, Nada ^a   Shalaby, Alaa ^b   Saad Hussein, Amal ^a   Ezzeldin, Howayda ^a   El Lebedy, Dalia Hassan ^a   Farouk, Hebatallah ^a   Kandil, Dina M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Adenovirus C; Chronic obstructive pulmonary disease; Single nucleotide polymorphism; Smoking

Indexed keywords

INTERLEUKIN 13; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS C GENE; ADENOVIRUS INFECTION; ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; EGYPT; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; SPIROMETRY; STATISTICAL SIGNIFICANCE; VIRUS GENE; VIRUS IDENTIFICATION;

EID: 84861464269     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.28556     Document Type: Article

References (36)

1. Molfino NA. Genetics of COPD. Chest 2004; 125: 1929-40. (Pubitemid 38648430)
2. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. The Proceedings of the American Thoracic Society 2006; 3: 405-8. (Pubitemid 44033353)
3. McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe obstruction pulmonary disease have a significant risk of airflow obstruction. Am J Resp Crit Care Med 2001; 164: 1419-24. (Pubitemid 33124020)
4. Wu L, Chau J, Young RP, et al. Transforming growth factorbeta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126-9. (Pubitemid 38223483)
5. El Bohy M, Ahmed M, Ezzeldin N, et al. Estimation of TGFbeta1 genotypes in Egyptian smokers: association with FEV1 in COPD patients. Arch Med Sci 2010; 6: 71-6.
6. Sakao S, Tatsumi K, Igari H, et al. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 420-2. (Pubitemid 32158522)
7. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-4.
8. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1179-84. (Pubitemid 30243827)
9. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-9. (Pubitemid 27505506)
10. Hersh CP, Demeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-8. (Pubitemid 40961016)
11. Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106: 1081-93.
12. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, et al. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 2002; 3: 436-9.
13. Edwards KM, Thompson J, Paolini J. Adenovirus infections in young children. Pediatrics 1985; 76: 420-4. (Pubitemid 15242509)
14. Samet JM, Tager IB, Speizer FE. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis 1983; 127: 508-23. (Pubitemid 13083758)
15. Matsuse T, Hayashi S, Kuwano K, et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146: 177-84.
16. Neumann R, Genersch E, Eggers HJ. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 1987; 7: 93-7. (Pubitemid 17031357)
17. Horvath J, Palkonyay L, Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J Virol 1987; 59: 189-92.
18. Bosken CH, Wiggs BR, Pare PD, et al. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis 1990; 142: 563-70. (Pubitemid 20292716)
19. American Thoracic Society. COPD criteria of diagnosis. Am J Resp Crit Care Med 1995; 152-77.
20. Garnett CT, Erdman D, Xu W, et al. Prevalence and quantization of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608-16. (Pubitemid 35176177)
21. Dolin R. Common viral respiratory infections and severe acute respiratory syndrome (SARS). In: Harrison's internal medicine. 17th ed. McGraw (ed.). Hill Professional 2008; Chapter 179.
22. Ezzeldin N, Motaweh A, Mohsen M, et al. Detection of a latent adenovirus C gene in children with recurrent respiratory tract infection. Passive smoking and infection. Egypt J Chest 2010; 59: 1-7.
23. Fletcher C, Peto RA. Natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-8. (Pubitemid 8124466)
24. Meshi B, Vitalis T, Ionescu D. Emphysematous lung destruction by cigarette smoke: the effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26: 52-7. (Pubitemid 34029820)
25. Ogawa E, Mark Elliott W, Hughes F, et al. Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD. Am J Physiol Lung Cell Mol Physiol 2004; 286: 189-97.
26. Wood AM, Stockley RA. The genetics of chronic obstructive pulmonary disease. Respir Res 2006; 7: 130.
27. Patuzzo C, Gile LS, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353-8. (Pubitemid 30321590)
28. Higham M, Pride N, Alikhan A, et al. Tumor necrosis factor-a gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-4. (Pubitemid 30085953)
29. Keatings VM, Cave SJ, Henry MJ, et al. A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest 2000; 118: 971-5.
30. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-320.
31. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001; 163: 469-73. (Pubitemid 32158530)
32. Lanus EC, De-Torres JP, Baz-Dávila R, et al. Siblings of patients with severe obstruction pulmonary disease have a significant risk of airflow obstruction. Am J Resp Crit Care Med 2001; 164: 1419-24.
33. Wilson AG, De Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-60. (Pubitemid 23117109)
34. Küçükaycan M, Van Krugten M, Pennings H, et al. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 2002; 3: 29.
35. Guo X, Lin HM, Lin Z, et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18: 482-90. (Pubitemid 32895633)
36. Hu R, Xu Y, Zhang Z. Surfactant protein B 1580 polymorphism is associated with susceptibility to chronic obstructive pulmonary disease in Chinese Han population. J Huazhong Univ Sci Technolog Med Sci 2004; 24: 216-38.